These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Huang WC; Huang LM; Chang IS; Chang LY; Chiang BL; Chen PJ; Wu MH; Lue HC; Lee CY; Pediatrics; 2009 Mar; 123(3):e401-5. PubMed ID: 19237439 [TBL] [Abstract][Full Text] [Related]
5. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Chang LY; Chang IS; Lu CY; Chiang BL; Lee CY; Chen PJ; Wang JT; Ho HN; Chen DS; Huang LM; Pediatrics; 2004 Dec; 114(6):e678-82. PubMed ID: 15574600 [TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of Kawasaki syndrome and the risk factors for coronary artery lesions in China. Ruan Y; Ye B; Zhao X Pediatr Infect Dis J; 2013 Oct; 32(10):e397-402. PubMed ID: 23722531 [TBL] [Abstract][Full Text] [Related]
7. Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Holman RC; Belay ED; Christensen KY; Folkema AM; Steiner CA; Schonberger LB Pediatr Infect Dis J; 2010 Jun; 29(6):483-8. PubMed ID: 20104198 [TBL] [Abstract][Full Text] [Related]
8. A 15-year review of children with Kawasaki's Syndrome having general anesthesia or deep sedation. Morrison JE; Anderson M; Chan KC; Pietra B; Zuk J; Gnadinger P Paediatr Anaesth; 2005 Dec; 15(12):1053-8. PubMed ID: 16324023 [TBL] [Abstract][Full Text] [Related]
11. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392 [TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin serum levels in Kawasaki disease: an additional potential marker in predicting children with coronary artery involvement. Simonini G; Masi L; Giani T; Piscitelli E; Cimaz R; Vierucci S; Brandi ML; Falcini F J Rheumatol; 2005 Nov; 32(11):2233-8. PubMed ID: 16265708 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of clinical characteristics of Kawasaki syndrome and risk factors for coronary artery abnormalities among children in Denmark. Patel A; Holman RC; Callinan LS; Sreenivasan N; Schonberger LB; Fischer TK; Belay ED Acta Paediatr; 2013 Apr; 102(4):385-90. PubMed ID: 23278838 [TBL] [Abstract][Full Text] [Related]
15. Possible relationship between streptococcal pyrogenic exotoxin A and Kawasaki syndrome in patients older than six months of age. Nomura Y; Masuda K; Yoshinaga M; Takei S; Miyata K Pediatr Infect Dis J; 2003 Sep; 22(9):794-8. PubMed ID: 14506370 [TBL] [Abstract][Full Text] [Related]
17. Lack of association of cervical lymphadenopathy and coronary artery complications in Kawasaki disease. Sung RY; Ng YM; Choi KC; Mok GC; Cheng YW; Ho MH; Pediatr Infect Dis J; 2006 Jun; 25(6):521-5. PubMed ID: 16732150 [TBL] [Abstract][Full Text] [Related]
18. Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms. Nofech-Mozes Y; Garty BZ Pediatr Hematol Oncol; 2003 Dec; 20(8):597-601. PubMed ID: 14578029 [TBL] [Abstract][Full Text] [Related]
19. Kawasaki disease in Auckland, 1979-1988. Gentles TL; Clarkson PM; Trenholme AA; Lennon DR; Neutze JM N Z Med J; 1990 Aug; 103(896):389-91. PubMed ID: 2385416 [TBL] [Abstract][Full Text] [Related]
20. Kawasaki syndrome hospitalizations and associated costs in the United States. Belay ED; Holman RC; Maddox RA; Foster DA; Schonberger LB Public Health Rep; 2003; 118(5):464-9. PubMed ID: 12941859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]